The respiratory stimulant effects of TRH and its analogs are relevant for identifying them as potential therapeutic agents in breathing disorders other than opioid-induced respiratory depression, such as those presented by patients with obstructive sleep apnea (OSA). The gene discussed is TRH; the disease is respiratory depression.